Message From Vystar Corp

This year continues to be very busy and productive and we're excited to share new developments on Vytex® Natural Rubber Latex (NRL). Most notably, Vystar and U.S. manufacturer Alatech Healthcare LLC received 510(k) clearance from the U.S. Food and Drug Administration to market and sell Alatech's Envy™ condom manufactured with Vytex NRL. Envy is the first condom on the U.S. market with specific labeling regarding antigenic protein claims and provides a new option and benefits for consumers. We anticipate the product will be available later this year.

In other news, we are presenting our third paper at the International Latex Conference in Cleveland, Ohio and had great response to our presentations at conferences earlier this year. We are following up on 55 manufacturing trials worldwide and have ramped up production in Asia and distribution globally. I had a productive trip to Malaysia and India in March and was pleased with the processing capacity in Malaysia and impressed with the research progress in India.

We are enthusiastic about our partnership with the American Latex Allergy Association, which advances our awareness campaign.

We look forward to keeping you informed and invite your feedback. Please email us at info@vytex.com or call (770) 965-0383.

Sincerely,
Bill Doyle, President & CEO, Vystar Corp.